Author: webedit

Updated Grand River Health COVID-19 cumulative stats for April 13, 2021

webedit

RIFLE, COLO. – The following are updated statistics from Grand River Health:

Grand River Health COVID-19 cumulative stats 4/13/2021
Number of individuals tested: 7,600
Positive results: 1,200
Pending results: 13
New positives since 4/8/21: 12
Patients admitted with COVID-19 since outbreak began: 47
Patients transferred: 12
Patients discharged: 34

Reported numbers are from Grand River Health only and could change at any time.

Vaccine Update: When vaccine is available, GRH is vaccinating the general public ages 16+. To know when COVID-19 vaccines become available, please watch the Grand River Health Facebook page and sign up for email alerts on the Grand River Health website at www.grandriverhealth.org.  There are no walk ins at this time. All vaccinations will be done by appointment only. We appreciate the community’s patience.

All clinic services, hospital and specialty services are open. All patients will be screened appropriately and patients with current symptoms will be scheduled for appointments in the respiratory clinic. 

All appointments can be made by calling 625-1100. Patients are asked to wear an ear loop mask while in the facility (no gators, bandanas or buffs please).

Updated Grand River Health COVID-19 cumulative stats for April 13, 2021

Updated Valley View COVID-19 cumulative stats

webedit

GLENWOOD SPRINGS, COLO. – The following are updated statistics from Valley View:

Valley View COVID-19 cumulative stats 4/13/21
Specimens collected thru Valley View: 24,919
Positive results: 2,034
Patients admitted with COVID-19 since outbreak began: 246
Admitted patients discharged: 222

Definitions:

Specimens collected: These are specimens collected by Valley View providers that are tested by Valley View’s laboratory in Glenwood Springs or sent to an outside laboratory to conduct COVID-19 testing. This is a cumulative number.

Positive results: These are the number of positive COVID-19 results returned from the Valley View specimens tested. This definition is updated on April 21 to clarify that the positive results represent positive patients. This is a cumulative number.

Patients admitted with COVID-19 since outreach began: Patients with a positive COVID-19 test who have been hospitalized at Valley View. This is a cumulative number.

Admitted patients discharged: Of admitted patients with a positive COVID-19 test, number who have been discharged from Valley View Hospital. Patients may be discharged to recover at home, to hospice or to psychiatric care. This is a cumulative number.  

Additional questions:

“From whom is Valley View collecting specimens?” Valley View is testing:

  • Patients who are symptomatic and have been referred by their primary care provider.
  • Patients undergoing medically necessary surgery.
  • Patients undergoing designated procedures that are high risk for aerosol generation.
  • Patients with a referral from their primary care provider for a test needed for work or travel.

“What kind of PCR test does Valley View offer?” Currently, Valley View has a nasopharyngeal PCR test. For the nasopharyngeal swab, a special swab of the nose occurs, it is then placed in a tube and sent for testing. 

“What is the difference between the number of patients admitted and number of patients discharged?” The difference between the number of patients and admitted patients discharged represents current hospitalized patients, patients transferred to other hospitals or those who have passed away. For example, if there are 21 patients admitted and 16 discharged, the difference is five. This is a cumulative number representing the entirety of Valley View’s efforts caring for COVID-19 patients. Therefore five total patients are hospitalized, have been transferred to a hospital as they need a higher level of care or, unfortunately, have passed away. Valley View will not offer additional details so as to protect their privacy.

“What is the turnaround for test results?”  At this point, Valley View is receiving test results same-day to 48 hours. The variability in time is due to the type of test ordered by the provider. For example, an individual experiencing a medical emergency may require a rapid test.

“The number of positive tests is not the same as admitted patients. Why?” Not all positive patients require hospitalization. For patients with mild symptoms, his/her doctor may recommend that they recover at home with specific instructions (e.g. isolation, monitor symptoms). Other positive patients may be very ill and need hospitalization.

“What is the status of these individual hospitalized patients?” Per the Health Insurance Portability and Accountability Act (HIPAA), Valley View will not speak to the specific status of an individual patient.

Updated Valley View COVID-19 cumulative stats

Update on Garfield County Public Health COVID-19 vaccine clinics for the week

webedit

CDC & FDA pause Johnson & Johnson, Public Health to offer Moderna

The Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA) have paused all Johnson and Johnson (J&J) vaccine administration. The clinic scheduled for the Carbondale Fire Department headquarters this evening, April 13, is providing Moderna vaccine to everyone who signed up. Those who receive their Moderna vaccine on April 13 are automatically scheduled for a second dose appointment on May 11 at the same time and in the same location. Those who wish to cancel their appointment should call 970-665-6371. Moderna is approved for anyone age 18 or older.

J&J adverse events appear to be extremely rare. More than 6.8 million doses of the vaccine have been distributed nationwide. The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in those who received the J&J vaccine. Safety is a top priority and Garfield County Public Health is pausing all distribution of J&J vaccine at this time.

People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care providers. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.html.

Public Health vaccine appointment sign up for the week

Public Health continues to post vaccine appointments available each week by Tuesday morning on the vaccine English webpage, Spanish webpage, and on Facebook @Garfieldhealth.

The specific clinic location is listed on the registration form, and anyone that signs up will receive a confirmation upon registration.

Carbondale, Tuesday April 13:
Currently full. The CDC & FDA have paused all Johnson & Johnson vaccine. Public health is keeping all appointments made for this clinic and offering Moderna instead. A second dose appointment is scheduled for May 11.

Glenwood Springs, Wednesday April 14:
Moderna vaccine for anyone age 18 or older. Second dose appointments are May 12.
Register here

Rifle, Thursday April 15:
Full: continue to check back as new appointments open if cancellations occur. Moderna vaccine for anyone age 18 or older. Second dose appointments are May 13.
Register here

__________________________________________________________________________________________________________

Actualización sobre clínicas de vacunación de COVID-19 de Salud Pública del Condado Garfield de la semana

Los CDC y la FDA pausan la vacuna Johnson & Johnson, Salud Pública ofrecerá Moderna

Los CDC y La FDA (por sus siglas en inglés) han pausado todas las vacunas Johnson y Johnson (J&J).  La clínica programada en el Departamento de Bomberos de Carbondale esta noche, 13 de abril, proporcionará la vacuna Moderna a todos los que se inscribieron.  Aquellos que reciban su vacuna Moderna el 13 de abril se programará automáticamente cita para la segunda dosis el 11 de mayo a la misma hora y en el mismo lugar.  Quienes deseen cancelar su cita deben llamar al 970-665-6371.  Moderna está aprobado para cualquier persona mayor de 18 años.

Los eventos adversos de J&J parecen ser extremadamente raros. Se han distribuido más de 6.8 millones de dosis de la vacuna en todo el país.  Los CDC y la FDA están revisando datos que involucran seis casos reportados en Estados Unidos de un tipo de coágulo sanguíneo raro y severo en quienes recibieron la vacuna J&J.  La seguridad es una prioridad máxima y Salud Pública del Condado Garfield pausará toda la distribución de la vacuna J&J en este momento.  Personas que hayan recibido la vacuna J&J y que presenten dolor de cabeza intenso, dolor abdominal, dolor en las piernas o dificultad para respirar dentro de las tres semanas después de la vacunación deben comunicarse con su médico.  Se solicita a los proveedores de atención médica notificar los eventos adversos al Sistema de Notificación de Eventos Adversos de vacunas en https://vaers.hhs.gov/reportevent.html.

Registro para cita de vacunación semanal de Salud Pública

Salud Pública seguirá publicando cada semana los martes en la mañana la disponibilidad de citas para vacunas en la página web de vacunas en inglés, página en español y en Facebook @Garfieldhealth.

La ubicación específica de la clínica aparece en el formulario de registro y recibirá una confirmación al registrarse.

Carbondale, martes 13 de abril:
Actualmente lleno. Los CDC y la FDA han pausado vacunación de Johnson & Johnson. Estamos cumpliendo con todas las citas programadas para esta clínica y ofreceremos Moderna en su lugar. Se le programará cita para el 11 de mayo para la segunda dosis.

Glenwood Springs, miércoles, 14 de abril:
Vacuna Moderna para personas mayor de 18 años. Se le programará cita para una segunda dosis pare el 12 de mayo. Registrarse aquí

Rifle, jueves, 15 de abril:
Lleno: continúe revisando ya que se abrirán citas si se hay cancelaciones. Vacuna Moderna para personas mayor de 18 años. Se le programará cita para el 13 de mayo para segunda dosis. Registrarse aquí

Update on Garfield County Public Health COVID-19 vaccine clinics for the week

CDPHE: Colorado pauses use of Johnson & Johnson COVID-19 vaccine after joint FDA and CDC announcement

webedit

In response to the joint CDC and FDA announcement and out of an abundance of caution, today the Colorado Department of Public Health and Environment (CDPHE) and the Colorado Joint Vaccine Task Force are alerting providers to temporarily pause use of the Johnson & Johnson (Janssen) COVID-19 vaccine. 

Federal health officials recommended temporarily suspending use of the vaccine after reviewing reports of six individuals in the U.S. who got rare and severe blood clots after receiving the vaccine. The federal government is allowing states to determine whether to pause use, and CDPHE is requiring providers to stop administration of the Johnson & Johnson (Janssen) vaccine until additional information becomes available. One of the reasons the FDA and CDC are recommending this pause is to ensure health care providers are aware of these potential but rare adverse events and can respond accordingly. The treatment for these types of blood clots is not the common treatment and thus time is needed to make sure healthcare providers know how to recognize and treat these rare occurrences. 

COVID-19 vaccine safety and the health and safety of all Coloradans is a top priority. These adverse events appear to be extremely rare. Individuals who received the Johnson & Johnson (Janssen) vaccine more than a month ago are at very low risk of serious side effects. Anyone who received the Johnson & Johnson (Janssen) vaccine within the last three weeks and who develops severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider. These symptoms are different from the flu-like symptoms people may experience after receiving a COVID-19 vaccine. Healthcare providers should report any adverse events to the Vaccine Adverse Event Reporting System (VAERS).

“In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the FDA and CDC stated in a joint statement.  

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will hold an emergency meeting Wednesday, April 14, to further review the cases and assess their potential significance, and the Food and Drug Administration will continue to investigate. The state will share additional information on how this affects Coloradans as soon as it becomes available. 

The Johnson & Johnson (Janssen) vaccine makes up only a small portion of Colorado’s weekly vaccine allocation. This week, for example, the state’s Johnson & Johnson (Janssen) allocation is 9,700, compared to nearly 280,000 doses of Pfizer and Moderna the state expects to receive this week. Most vaccine clinics will not be significantly affected. 

Anyone scheduled to receive the Johnson & Johnson (Janssen) vaccine will either receive the Pfizer or Moderna vaccine instead, or the vaccine provider will contact them to reschedule their appointment once FDA and CDC release additional information. 

The state’s mobile vaccination buses, which have been administering only the Johnson & Johnson (Janssen) vaccine, are canceled today and Wednesday. More information will be provided when it becomes available. 

Providers who already have a Johnson & Johnson (Janssen) vaccine supply should keep it and continue to maintain proper storage. 

Continue to stay up to date by visiting covid19.colorado.gov.

CDPHE: Colorado pauses use of Johnson & Johnson COVID-19 vaccine after joint FDA and CDC announcement

CDPHE: State adds percentage of residents vaccinated by county to vaccine data dashboard

webedit

The state has updated its COVID-19 vaccine data dashboard to reflect the percentage of residents at least partially vaccinated or fully vaccinated by county. This new data supplements current county level data regarding doses distributed and doses administered to provide a more comprehensive snapshot of vaccination progress by county.

The two new data tabs and their definitions are:

1+ Vaccination Rate: the percentage of people who have received at least one dose of any COVID-19 vaccine. This includes people who have received at least one dose of Pfizer, Moderna, or Janssen (Johnson & Johnson) vaccine. If an individual has received more than one dose, they will also be counted in the Up-to-Date Vaccination Rate. This data is based on the immunized person’s county of residence as listed in the Colorado Immunization Information System (CIIS).

Up-to-Date Vaccination Rate: the percentage of people who have received at least two doses of either Pfizer or Moderna vaccine, or who have received at least one dose of Janssen (Johnson & Johnson) vaccine. Any individual with a second dose administered on a different day than the initial dose will be counted as receiving two doses. These individuals are also counted in the 1+ Vaccination Rate data. This data is based on the immunized person’s county of residence as listed in the Colorado Immunization Information System (CIIS). 

Continue to stay up to date by visiting covid19.colorado.gov.

____________________________________________________________________________________

El estado añade porcentaje de residentes vacunados por condado, al tablero de datos de vacunas

REMOTO, (8 de abril de 2021): Hoy, el estado actualizó su tablero de datos de vacunas del COVID-19 para reflejar el porcentaje de residentes por condado que al menos fueron parcialmente vacunados o fueron completamente vacunados. Estos datos nuevos complementan los datos  actuales  de los condados con respecto a dosis distribuidas y dosis administradas para proveer un resumen más comprensible del progreso de vacunación por condado. 

Los dos tabuladores nuevos de datos y sus definiciones son:

1+ Índice de Vacunación: el porcentaje de personas que han recibido al menos una dosis de cualquiera de las vacunas contra el COVID-19. Esto incluye personas que han recibido al menos una dosis de las vacunas Pfizer, Moderna, o Janssen (Johnson & Johnson). Si un individuo ha recibido más de una dosis, será contado en el Índice de Vacunación Actual. Estos datos están basados en el condado de residencia de la persona inmunizada según está inscrito en el Sistema de Información de Inmunización de Colorado (CIIS, según sus siglas en inglés). 

Resumen Actualizado de Vacunación: el porcentaje de personas que han recibido al menos dos dosis de la vacuna Pfizer o de Moderna, o que han recibido al menos una dosis de la vacuna Janssen (Johnson & Johnson). Cualquier individuo que haya sido administrado con una segunda dosis en un día diferente a la dosis inicial será contado como si hubiera recibido dos dosis. Estos individuos también serán contados en el 1+ Índice de Vacunación. Estos datos están basados en el condado de residencia de la persona inmunizada según está registrado en el  Sistema de Información de Inmunización de Colorado (CIIS, según sus siglas en inglés). 

Continúe manteniéndose al día visitando covid19.colorado.gov. 

CDPHE: State adds percentage of residents vaccinated by county to vaccine data dashboard

Roaring Fork Schools: BMS transitions 8th grade to distance learning

webedit

A student or staff member at Basalt Middle School has tested positive for COVID-19. Families of students who may have been exposed and need to quarantine have been contacted directly. The entire 8th grade class will begin distance learning with online classes starting immediately on Friday, April 9 and continuing through Monday, April 12. Students will return to in-person classes on Tuesday, April 13. Sports practices and games are canceled April 8 and 9 and resume Monday, April 12 after 3:15pm.

The affected areas in the school will be deep cleaned and disinfected prior to the return of non-impacted students and staff. Students in grades 5-7 will remain in normal session.

Roaring Fork Schools: BMS transitions 8th grade to distance learning

Updated Grand River Health COVID-19 cumulative stats for April 8, 2021

webedit

RIFLE, COLO. – The following are updated statistics from Grand River Health:

Grand River Health COVID-19 cumulative stats – 4/8/2021

Number of individuals tested: 7,499
Positive results: 1,188
Pending results: 18
New positives since 4/6/21: 2
Patients admitted with COVID-19 since outbreak began: 46
Patients transferred: 12
Patients discharged: 34

Reported numbers are from Grand River Health only and could change at any time.

Vaccine Update: When vaccine is available, GRH is vaccinating the general public ages 16+.  To know when COVID-19 vaccines become available, please watch the Grand River Health Facebook page and sign up for email alerts on the Grand River Health website at www.grandriverhealth.org.  There are no walk ins at this time. All vaccinations will be done by appointment only. We appreciate the community’s patience.

All clinic services, hospital and specialty services are open. All patients will be screened appropriately and patients with current symptoms will be scheduled for appointments in the respiratory clinic. 

All appointments can be made by calling 625-1100. Patients are asked to wear an ear loop mask while in the facility (no gators, bandanas or buffs please).

Updated Grand River Health COVID-19 cumulative stats for April 8, 2021

Updated Valley View COVID-19 cumulative stats

webedit

GLENWOOD SPRINGS, COLO. – The following are updated statistics from Valley View:

Valley View COVID-19 cumulative stats – 4/8/21

Specimens collected thru Valley View: 24,657
Positive results: 2,012
Patients admitted with COVID-19 since outbreak began: 244
Admitted patients discharged: 220

Definitions:

Specimens collected: These are specimens collected by Valley View providers that are tested by Valley View’s laboratory in Glenwood Springs or sent to an outside laboratory to conduct COVID-19 testing. This is a cumulative number.

Positive results: These are the number of positive COVID-19 results returned from the Valley View specimens tested. This definition is updated on April 21 to clarify that the positive results represent positive patients. This is a cumulative number.

Patients admitted with COVID-19 since outreach began: Patients with a positive COVID-19 test who have been hospitalized at Valley View. This is a cumulative number.

Admitted patients discharged: Of admitted patients with a positive COVID-19 test, number who have been discharged from Valley View Hospital. Patients may be discharged to recover at home, to hospice or to psychiatric care. This is a cumulative number.  

Additional questions:

“From whom is Valley View collecting specimens?” Valley View is testing:

  • Patients who are symptomatic and have been referred by their primary care provider.
  • Patients undergoing medically necessary surgery.
  • Patients undergoing designated procedures that are high risk for aerosol generation.
  • Patients with a referral from their primary care provider for a test needed for work or travel.

“What kind of PCR test does Valley View offer?” Currently, Valley View has a nasopharyngeal PCR test. For the nasopharyngeal swab, a special swab of the nose occurs, it is then placed in a tube and sent for testing. 

“What is the difference between the number of patients admitted and number of patients discharged?” The difference between the number of patients and admitted patients discharged represents current hospitalized patients, patients transferred to other hospitals or those who have passed away. For example, if there are 21 patients admitted and 16 discharged, the difference is five. This is a cumulative number representing the entirety of Valley View’s efforts caring for COVID-19 patients. Therefore five total patients are hospitalized, have been transferred to a hospital as they need a higher level of care or, unfortunately, have passed away. Valley View will not offer additional details so as to protect their privacy.

“What is the turnaround for test results?”  At this point, Valley View is receiving test results same-day to 48 hours. The variability in time is due to the type of test ordered by the provider. For example, an individual experiencing a medical emergency may require a rapid test.

“The number of positive tests is not the same as admitted patients. Why?” Not all positive patients require hospitalization. For patients with mild symptoms, his/her doctor may recommend that they recover at home with specific instructions (e.g. isolation, monitor symptoms). Other positive patients may be very ill and need hospitalization.

“What is the status of these individual hospitalized patients?” Per the Health Insurance Portability and Accountability Act (HIPAA), Valley View will not speak to the specific status of an individual patient.

Updated Valley View COVID-19 cumulative stats

Governor Polis takes action in response to COVID-19 pandemic

webedit

DENVER – Governor Polis took action in response to the COVID-19 pandemic. 

Governor Polis extended an executive order temporarily suspending certain regulatory statutes concerning criminal justice. 

The governor amended an executive order related to the temporary suspension of certain statutes to increase the Medicaid home health workforce and eliminate cost sharing for COVID-19 testing and treatment for Medicaid enrollees. The amendments continue statutory suspensions  for cost sharing for COVID-19 testing and treatment for Medicaid enrollees and direct and indirect health care services costs, while allowing the other provisions to expire.

Governor Polis takes action in response to COVID-19 pandemic

CDPHE: COVID-19 P.1 variant detected in Colorado

webedit

The Centers for Disease Control and Response (CDC) have notified the Colorado Department of Public Health and Environment (CDPHE) of its first COVID-19 P.1 variant cases (2) in Colorado. Public health officials originally identified the P.1 variant among travelers from Brazil arriving in Japan. This is the first detection of P.1 in the state, but to date 289 cases have been identified across 25 jurisdictions in the U.S. The variant cases are residents of Boulder county. Prior travel history for both individuals is unknown at this time. CDPHE is investigating possible exposures and performing contact tracing to determine if the variant virus has spread to others. Boulder County Public Health is working closely with CDPHE to provide local support if needed or requested. 

Coloradans should continue to wear masks, practice physical distancing, wash their hands frequently, and get vaccinated when it is their turn. These are our best tools for preventing the spread of this virus, no matter the strain. Early research suggests that the currently authorized vaccines are effective against known variants, though perhaps to varying degrees depending on the strain. Experts stress that getting vaccinated can provide significant protection against transmission and severe illness from COVID-19. 

Continue to stay up to date by visiting covid19.colorado.gov. All detected variants in Colorado are listed on the data dashboard and the CDC has a webpage dedicated to COVID-19 variants.

______________________________________________________________________________________________

CDPHE: Se detectó la variante P.1 del COVID-19 en Colorado

REMOTO, (6 de abril de 2021): Los Centros para el Control y la Prevención de Enfermedades (CDC, por sus siglas en inglés) han notificado al Departamento de Salud Pública y Medio Ambiente de Colorado (CDPHE, por sus siglas en inglés) sobre sus primeros (2) casos de la variante P.1 del COVID-19 en Colorado. Los funcionarios de salud pública identificaron originalmente la variante P.1 entre personas viajando desde Brasil hacia Japón. Esta es la primera detección de P.1 en el estado, pero hasta la fecha se han identificado 289 casos en 25 jurisdicciones en los EE.UU. Los casos de la variante son residentes del condado Boulder. Por ahora se desconoce el historial de viaje de ambas personas. El CDPHE está investigando las posibles exposiciones y realizando rastreo de contactos para determinar si la variante del virus se ha propagado a otras personas. La agencia de Salud Pública del Condado Boulder está trabajando de cerca con el CDPHE para brindar apoyo local, si es necesario o solicitado. 

Los habitantes de Colorado deben continuar usando tapabocas, practicar el distanciamiento físico, lavarse las manos con frecuencia y vacunarse cuando sea su turno. Estas son nuestras mejores herramientas para prevenir la propagación de este virus, sin importar la cepa. Las primeras investigaciones sugieren que las vacunas actualmente autorizadas son eficaces contra las variantes conocidas, aunque quizás en diferentes grados dependiendo de la cepa. Los expertos enfatizan que vacunarse puede proporcionar una protección significativa contra la transmisión y la enfermedad grave del COVID-19. 

Continúe manteniéndose informado visitando covid19.colorado.gov. Todas las variantes detectadas en Colorado aparecen en el tablero de datos y los CDC tienen un sitio web dedicado a las variantes del COVID-19.

CDPHE: COVID-19 P.1 variant detected in Colorado